It is reasonable to speculate that bio-characterization of CTCs isolated by anti-EpCAM might be perturbed with unpredictable artifacts upon antibody binding to EpCAM, an active signaling molecule on tumor cells [16, 18, 26, 27]. Here, EPCAM is linked to neoplasm.